337 related articles for article (PubMed ID: 32474952)
1. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
[TBL] [Abstract][Full Text] [Related]
2. The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.
Corrêa MP; Areias LL; Correia-Silva RD; D'Ávila SCGP; Leopoldino AM; Greco KV; Gil CD
Cells; 2021 Apr; 10(4):. PubMed ID: 33923930
[TBL] [Abstract][Full Text] [Related]
3. Expression Pattern and Immunoregulatory Roles of Galectin-1 and Galectin-3 in Atopic Dermatitis and Psoriasis.
Corrêa MP; Correia-Silva RD; Sasso GRS; D'Ávila SCGP; Greco KV; Oliani SM; Gil CD
Inflammation; 2022 Jun; 45(3):1133-1145. PubMed ID: 35031944
[TBL] [Abstract][Full Text] [Related]
4. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
Kamsteeg M; Bergers M; de Boer R; Zeeuwen PL; Hato SV; Schalkwijk J; Tjabringa GS
Am J Pathol; 2011 May; 178(5):2091-9. PubMed ID: 21514424
[TBL] [Abstract][Full Text] [Related]
5. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of suprabasin induces aberrant differentiation and apoptosis of epidermal keratinocytes: Possible role for atopic dermatitis.
Aoshima M; Phadungsaksawasdi P; Nakazawa S; Iwasaki M; Sakabe JI; Umayahara T; Yatagai T; Ikeya S; Shimauchi T; Tokura Y
J Dermatol Sci; 2019 Sep; 95(3):107-112. PubMed ID: 31399284
[TBL] [Abstract][Full Text] [Related]
7. Lipid abnormalities in atopic skin are driven by type 2 cytokines.
Berdyshev E; Goleva E; Bronova I; Dyjack N; Rios C; Jung J; Taylor P; Jeong M; Hall CF; Richers BN; Norquest KA; Zheng T; Seibold MA; Leung DY
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467325
[TBL] [Abstract][Full Text] [Related]
8. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
[TBL] [Abstract][Full Text] [Related]
10. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
11. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip.
Kim K; Kim H; Sung GY
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216228
[TBL] [Abstract][Full Text] [Related]
12. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
Bao L; Shi VY; Chan LS
Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
[TBL] [Abstract][Full Text] [Related]
13. A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis.
Bao L; Mohan GC; Alexander JB; Doo C; Shen K; Bao J; Chan LS
Innate Immun; 2017 Nov; 23(8):641-647. PubMed ID: 28952836
[TBL] [Abstract][Full Text] [Related]
14. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
Lee J; Song KM; Jung CH
Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
[TBL] [Abstract][Full Text] [Related]
15. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.
Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y
PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419
[TBL] [Abstract][Full Text] [Related]
16. Methyl-β-cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model.
do Nascimento Pedrosa T; De Vuyst E; Mound A; Lambert de Rouvroit C; Maria-Engler SS; Poumay Y
Arch Dermatol Res; 2017 Jan; 309(1):63-69. PubMed ID: 27833999
[TBL] [Abstract][Full Text] [Related]
17. Galectin-7 in the stratum corneum: a biomarker of the skin barrier function.
Niiyama S; Yoshino T; Yasuda C; Yu X; Izumi R; Ishiwatari S; Matsukuma S; Mukai H
Int J Cosmet Sci; 2016 Oct; 38(5):487-95. PubMed ID: 27028525
[TBL] [Abstract][Full Text] [Related]
18. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
20. Cytokine modulation of atopic dermatitis filaggrin skin expression.
Howell MD; Kim BE; Gao P; Grant AV; Boguniewicz M; Debenedetto A; Schneider L; Beck LA; Barnes KC; Leung DY
J Allergy Clin Immunol; 2007 Jul; 120(1):150-5. PubMed ID: 17512043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
